The emerging treatment of the medication represents a exciting breakthrough in the management of type 2 diabetes. Distinct from existing therapies, tirzepatide affects dual pathways – GLP-1 and GIP – leading to https://tirzepatidepeptide222340.thelateblog.com/42364556/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment